Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23045188 | 0.98 | ALDH1A1 (0.44) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL218038 | 0.98 | ALDH1A1 (0.44) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL215988 | 0.98 | ALDH1A1 (0.44) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL59221 | 0.96 | THRB (0.44) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL1655574 | 0.94 | THRB (0.43) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL60306 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL23498428 | 0.92 | ALDH1A1 (0.48) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| Propionic Acid SCHEMBL4955445 | 0.90 | THRB (0.41) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| Methacrylic Acid SCHEMBL3685193 | 0.90 | ALDH1A1 (0.39) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL4102986 | 0.90 | THRB (0.41) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1464 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | SHOFU INC. (JP) | 2026-02-17 | — | — | US | claimed |
| US-20250263566-A1 | CASTING LACQUER FOR SCREEN PRINTING | DE LA RUE INTERNATIONAL LIMITED (GB) | 2025-08-21 | — | — | US | claimed |
| US-12280196-B2 | Methods of using polymers | CYTOSORBENTS, INC. (US) | 2025-04-22 | — | — | US | claimed |
| EP-4490577-A1 | CASTING LACQUER FOR SCREEN PRINTING | BASF SE (DE) | 2025-01-15 | — | — | EP | claimed |
| US-20250009951-A1 | IMPROVED CANCER IMMUNOTHERAPY TREATMENTS | CYTOSORBENTS CORPORATION | 2025-01-09 | — | — | US | claimed |
| CN-118891584-A | Casting paint for screen printing | 巴斯夫欧洲公司 | 2024-11-01 | — | — | CN | claimed |
| EP-4440657-A1 | IMPROVED CANCER IMMUNOTHERAPY TREATMENTS | Cytosorbents Corporation (US) | 2024-10-09 | — | — | EP | claimed |
| CN-118613294-A | Improved cancer immunotherapy treatment | 西托索尔本茨公司 | 2024-09-06 | — | — | CN | claimed |
| US-12076474-B2 | Method of treating traumatic brain injury | CYTOSORBENTS, INC. (US) | 2024-09-03 | — | — | US | claimed |
| US-20240197977-A1 | IMPROVED IMMUNE RESPONSE AND DECREASED IMMUNOPARALYSIS WITH IMMUNOMODULATING TREATMENT | CYTOSORBENTS CORPORATION | 2024-06-20 | — | — | US | claimed |
| US-4587200-A | Photopolymerizable composition comprising an acridine and a heterocyclic thiol compound as a photopolymerization initiator and a photographic process using said photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1986-05-06 | — | — | US | claimed |
| US-4537855-A | PHOTOPOLYMERIZABLE HIGH MOLECULAR WEIGHT COMPOUND HAVING POLYFUCTIONAL ETHYLENICALLY UNSATURATED SIDE CHAIN OR END GROUPS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1985-08-27 | — | — | US | claimed |
| US-4439515-A | Light-sensitive ethylenically unsaturated materials containing benzanthrones and novel sensitizers | FUJI PHOTO FILM CO., LTD. (JP) | 1984-03-27 | — | — | US | claimed |
| US-4386153-A | PROMOTER IS MIXTURE OF A BENZANTHRONE OR 1,2-BENZANTHRAQUINONE, AND AN OXO OR CARBOXY AROMATIC AMINE | FUJI PHOTO FILM CO., LTD. (JP) | 1983-05-31 | — | — | US | claimed |
| US-4367280-A | AROMATIC CARBONYL COMPOUND AND P-DIALKYLAMINO AROMATIC CARBONYL COMPOUND COMBINATION POLYMERIZATION INITIATOR | FUJI PHOTO FILM CO., LTD. (JP) | 1983-01-04 | — | — | US | claimed |
| US-4308119-A | Abrasion-resistant optical coating composition containing pentaerythritol based polyacrylates and cellulose esters | PANELGRAPHIC CORPORATION (US) | 1981-12-29 | — | — | US | claimed |
| US-4298679-A | PHOTOPOLYMERIZABLE MONOMER, PHOTOINITIATOR | FUJI PHOTO FILM CO., LTD. (JP) | 1981-11-03 | — | — | US | claimed |
| WO-1980001805-A1 | RADIATION CURABLE CELLULOSIC POLYACRYLIC ABRASION RESISTANT COATING | PANELGRAPHIC CORP (US) | 1980-09-04 | — | — | WO | claimed |
| US-4175971-A | INITIATOR OF BENZANTHRONE OR 1,2-BENANTHRO QUINONE OR DERIVATIVES AND A 4,4*-BIS/DIALKYLAMINO/BENZOPHENONE | FUJI PHOTO FILM CO., LTD. (JP) | 1979-11-27 | — | — | US | claimed |
| US-4148658-A | BENZOYLMETHYLENE-BENSOTHIAZOLYIDEND-THIAZOLIDONE COMPOUND, AMINE, AND AMINOARYLCARBONYL COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1979-04-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | CDH1, DCLRE1A, ITGA1 | ALDH1A1 50/4885TP53 2864/4885CYP3A4 3614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.